SIGA Technologies, Inc. Profile Avatar - Palmy Investing

SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox dise…

Drug Manufacturers - Specialty & Generic
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

SIGA Technologies, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

SIGA Technologies, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of SIGA Technologies, Inc..

End of SIGA's Analysis
CIK: 1010086 CUSIP: 826917106 ISIN: US8269171067 LEI: - UEI: -
Secondary Listings
SIGA has no secondary listings inside our databases.